nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Methotrexate—stomach cancer	0.19	0.326	CbGbCtD
Zaleplon—CYP3A7—Irinotecan—stomach cancer	0.0725	0.124	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0725	0.124	CbGbCtD
Zaleplon—CYP3A5—Irinotecan—stomach cancer	0.0544	0.0931	CbGbCtD
Zaleplon—CYP3A7—Docetaxel—stomach cancer	0.0532	0.091	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0532	0.091	CbGbCtD
Zaleplon—CYP3A5—Docetaxel—stomach cancer	0.0399	0.0682	CbGbCtD
Zaleplon—CYP3A4—Irinotecan—stomach cancer	0.0212	0.0363	CbGbCtD
Zaleplon—CYP3A4—Docetaxel—stomach cancer	0.0155	0.0266	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—stomach cancer	0.0116	0.0198	CbGbCtD
Zaleplon—AOX1—gall bladder—stomach cancer	0.00272	0.09	CbGeAlD
Zaleplon—TSPO—blood vessel—stomach cancer	0.00247	0.0817	CbGeAlD
Zaleplon—CYP3A7—endocrine gland—stomach cancer	0.00133	0.044	CbGeAlD
Zaleplon—TSPO—hematopoietic system—stomach cancer	0.00132	0.0435	CbGeAlD
Zaleplon—AOX1—pancreas—stomach cancer	0.00125	0.0415	CbGeAlD
Zaleplon—TSPO—epithelium—stomach cancer	0.0012	0.0398	CbGeAlD
Zaleplon—CYP3A7—liver—stomach cancer	0.0012	0.0397	CbGeAlD
Zaleplon—TSPO—smooth muscle tissue—stomach cancer	0.00116	0.0383	CbGeAlD
Zaleplon—TSPO—pancreas—stomach cancer	0.00107	0.0354	CbGeAlD
Zaleplon—AOX1—digestive system—stomach cancer	0.00107	0.0354	CbGeAlD
Zaleplon—CYP3A7-CYP3A51P—liver—stomach cancer	0.00102	0.0337	CbGeAlD
Zaleplon—GABRB3—pancreas—stomach cancer	0.000973	0.0322	CbGeAlD
Zaleplon—TSPO—lymphoid tissue—stomach cancer	0.000926	0.0306	CbGeAlD
Zaleplon—TSPO—digestive system—stomach cancer	0.000915	0.0303	CbGeAlD
Zaleplon—AOX1—endocrine gland—stomach cancer	0.000885	0.0293	CbGeAlD
Zaleplon—TSPO—bone marrow—stomach cancer	0.000843	0.0279	CbGeAlD
Zaleplon—CYP3A5—hematopoietic system—stomach cancer	0.000815	0.0269	CbGeAlD
Zaleplon—AOX1—liver—stomach cancer	0.000798	0.0264	CbGeAlD
Zaleplon—TSPO—endocrine gland—stomach cancer	0.000756	0.025	CbGeAlD
Zaleplon—GABRB3—endocrine gland—stomach cancer	0.000686	0.0227	CbGeAlD
Zaleplon—TSPO—liver—stomach cancer	0.000682	0.0225	CbGeAlD
Zaleplon—CYP3A5—pancreas—stomach cancer	0.000663	0.0219	CbGeAlD
Zaleplon—GABRB3—liver—stomach cancer	0.000619	0.0205	CbGeAlD
Zaleplon—AOX1—lymph node—stomach cancer	0.000612	0.0202	CbGeAlD
Zaleplon—CYP3A4—hematopoietic system—stomach cancer	0.000611	0.0202	CbGeAlD
Zaleplon—CYP3A5—digestive system—stomach cancer	0.000567	0.0187	CbGeAlD
Zaleplon—GABRA2—lymph node—stomach cancer	0.000564	0.0187	CbGeAlD
Zaleplon—TSPO—lymph node—stomach cancer	0.000523	0.0173	CbGeAlD
Zaleplon—CYP3A5—endocrine gland—stomach cancer	0.000468	0.0155	CbGeAlD
Zaleplon—CYP3A4—digestive system—stomach cancer	0.000425	0.0141	CbGeAlD
Zaleplon—CYP3A5—liver—stomach cancer	0.000422	0.014	CbGeAlD
Zaleplon—CYP3A4—endocrine gland—stomach cancer	0.000351	0.0116	CbGeAlD
Zaleplon—CYP3A4—liver—stomach cancer	0.000317	0.0105	CbGeAlD
Zaleplon—Dry mouth—Capecitabine—stomach cancer	0.000205	0.000544	CcSEcCtD
Zaleplon—Pneumonia—Doxorubicin—stomach cancer	0.000205	0.000543	CcSEcCtD
Zaleplon—Shock—Docetaxel—stomach cancer	0.000204	0.000542	CcSEcCtD
Zaleplon—Nervous system disorder—Docetaxel—stomach cancer	0.000204	0.000541	CcSEcCtD
Zaleplon—Pruritus—Fluorouracil—stomach cancer	0.000204	0.00054	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—stomach cancer	0.000203	0.000539	CcSEcCtD
Zaleplon—Confusional state—Capecitabine—stomach cancer	0.000203	0.000538	CcSEcCtD
Zaleplon—Tachycardia—Docetaxel—stomach cancer	0.000203	0.000538	CcSEcCtD
Zaleplon—Skin disorder—Docetaxel—stomach cancer	0.000202	0.000535	CcSEcCtD
Zaleplon—Oedema—Capecitabine—stomach cancer	0.000201	0.000534	CcSEcCtD
Zaleplon—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000199	0.000529	CcSEcCtD
Zaleplon—Dizziness—Irinotecan—stomach cancer	0.000199	0.000527	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—stomach cancer	0.000198	0.000526	CcSEcCtD
Zaleplon—Anorexia—Docetaxel—stomach cancer	0.000198	0.000525	CcSEcCtD
Zaleplon—Shock—Capecitabine—stomach cancer	0.000198	0.000525	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—stomach cancer	0.000198	0.000524	CcSEcCtD
Zaleplon—Nervous system disorder—Capecitabine—stomach cancer	0.000197	0.000523	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—stomach cancer	0.000197	0.000523	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—stomach cancer	0.000197	0.000521	CcSEcCtD
Zaleplon—Tachycardia—Capecitabine—stomach cancer	0.000196	0.000521	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—stomach cancer	0.000196	0.000521	CcSEcCtD
Zaleplon—Skin disorder—Capecitabine—stomach cancer	0.000195	0.000518	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—stomach cancer	0.000195	0.000517	CcSEcCtD
Zaleplon—Hyperhidrosis—Capecitabine—stomach cancer	0.000195	0.000516	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—stomach cancer	0.000194	0.000516	CcSEcCtD
Zaleplon—Hypotension—Docetaxel—stomach cancer	0.000194	0.000515	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—stomach cancer	0.000194	0.000514	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000192	0.00051	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—stomach cancer	0.000192	0.000509	CcSEcCtD
Zaleplon—Anorexia—Capecitabine—stomach cancer	0.000192	0.000509	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—stomach cancer	0.00019	0.000505	CcSEcCtD
Zaleplon—Dizziness—Fluorouracil—stomach cancer	0.00019	0.000505	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—stomach cancer	0.00019	0.000504	CcSEcCtD
Zaleplon—Rash—Irinotecan—stomach cancer	0.00019	0.000503	CcSEcCtD
Zaleplon—Dermatitis—Irinotecan—stomach cancer	0.000189	0.000502	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000189	0.000502	CcSEcCtD
Zaleplon—Chills—Methotrexate—stomach cancer	0.000189	0.000502	CcSEcCtD
Zaleplon—Headache—Irinotecan—stomach cancer	0.000188	0.0005	CcSEcCtD
Zaleplon—Hypotension—Capecitabine—stomach cancer	0.000188	0.000499	CcSEcCtD
Zaleplon—Insomnia—Docetaxel—stomach cancer	0.000188	0.000499	CcSEcCtD
Zaleplon—Paraesthesia—Docetaxel—stomach cancer	0.000187	0.000495	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—stomach cancer	0.000186	0.000494	CcSEcCtD
Zaleplon—Dyspnoea—Docetaxel—stomach cancer	0.000185	0.000491	CcSEcCtD
Zaleplon—Somnolence—Docetaxel—stomach cancer	0.000185	0.00049	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—stomach cancer	0.000185	0.00049	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—stomach cancer	0.000184	0.000489	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—stomach cancer	0.000184	0.000488	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—stomach cancer	0.000184	0.000487	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000183	0.000486	CcSEcCtD
Zaleplon—Dyspepsia—Docetaxel—stomach cancer	0.000183	0.000485	CcSEcCtD
Zaleplon—Insomnia—Capecitabine—stomach cancer	0.000182	0.000483	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—stomach cancer	0.000182	0.000482	CcSEcCtD
Zaleplon—Rash—Fluorouracil—stomach cancer	0.000182	0.000482	CcSEcCtD
Zaleplon—Dermatitis—Fluorouracil—stomach cancer	0.000181	0.000481	CcSEcCtD
Zaleplon—Paraesthesia—Capecitabine—stomach cancer	0.000181	0.000479	CcSEcCtD
Zaleplon—Decreased appetite—Docetaxel—stomach cancer	0.000181	0.000479	CcSEcCtD
Zaleplon—Headache—Fluorouracil—stomach cancer	0.00018	0.000478	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—stomach cancer	0.00018	0.000477	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—stomach cancer	0.00018	0.000477	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000179	0.000476	CcSEcCtD
Zaleplon—Dyspnoea—Capecitabine—stomach cancer	0.000179	0.000476	CcSEcCtD
Zaleplon—Nausea—Irinotecan—stomach cancer	0.000179	0.000474	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—stomach cancer	0.000178	0.000473	CcSEcCtD
Zaleplon—Constipation—Docetaxel—stomach cancer	0.000178	0.000471	CcSEcCtD
Zaleplon—Pain—Docetaxel—stomach cancer	0.000178	0.000471	CcSEcCtD
Zaleplon—Back pain—Methotrexate—stomach cancer	0.000178	0.000471	CcSEcCtD
Zaleplon—Dyspepsia—Capecitabine—stomach cancer	0.000177	0.00047	CcSEcCtD
Zaleplon—Chills—Epirubicin—stomach cancer	0.000177	0.00047	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—stomach cancer	0.000176	0.000467	CcSEcCtD
Zaleplon—Decreased appetite—Capecitabine—stomach cancer	0.000175	0.000464	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—stomach cancer	0.000174	0.000462	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000174	0.000461	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—stomach cancer	0.000173	0.000458	CcSEcCtD
Zaleplon—Constipation—Capecitabine—stomach cancer	0.000172	0.000456	CcSEcCtD
Zaleplon—Pain—Capecitabine—stomach cancer	0.000172	0.000456	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—stomach cancer	0.000172	0.000456	CcSEcCtD
Zaleplon—Feeling abnormal—Docetaxel—stomach cancer	0.000171	0.000454	CcSEcCtD
Zaleplon—Nausea—Fluorouracil—stomach cancer	0.000171	0.000454	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—stomach cancer	0.000171	0.000453	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—stomach cancer	0.00017	0.000452	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—stomach cancer	0.00017	0.000451	CcSEcCtD
Zaleplon—Gastrointestinal pain—Docetaxel—stomach cancer	0.00017	0.000451	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—stomach cancer	0.00017	0.00045	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—stomach cancer	0.000169	0.000449	CcSEcCtD
Zaleplon—Tension—Epirubicin—stomach cancer	0.000169	0.000447	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—stomach cancer	0.000168	0.000446	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—stomach cancer	0.000167	0.000442	CcSEcCtD
Zaleplon—Back pain—Epirubicin—stomach cancer	0.000166	0.000441	CcSEcCtD
Zaleplon—Feeling abnormal—Capecitabine—stomach cancer	0.000166	0.00044	CcSEcCtD
Zaleplon—Malaise—Methotrexate—stomach cancer	0.000166	0.000439	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—stomach cancer	0.000165	0.000437	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—stomach cancer	0.000165	0.000437	CcSEcCtD
Zaleplon—Gastrointestinal pain—Capecitabine—stomach cancer	0.000165	0.000436	CcSEcCtD
Zaleplon—Abdominal pain—Docetaxel—stomach cancer	0.000164	0.000436	CcSEcCtD
Zaleplon—Body temperature increased—Docetaxel—stomach cancer	0.000164	0.000436	CcSEcCtD
Zaleplon—Chills—Doxorubicin—stomach cancer	0.000164	0.000434	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—stomach cancer	0.000161	0.000428	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—stomach cancer	0.00016	0.000424	CcSEcCtD
Zaleplon—Urticaria—Capecitabine—stomach cancer	0.00016	0.000424	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—stomach cancer	0.000159	0.000423	CcSEcCtD
Zaleplon—Abdominal pain—Capecitabine—stomach cancer	0.000159	0.000422	CcSEcCtD
Zaleplon—Body temperature increased—Capecitabine—stomach cancer	0.000159	0.000422	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—stomach cancer	0.000159	0.000422	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—stomach cancer	0.000159	0.000421	CcSEcCtD
Zaleplon—Agitation—Epirubicin—stomach cancer	0.000158	0.000419	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—stomach cancer	0.000157	0.000415	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—stomach cancer	0.000156	0.000414	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—stomach cancer	0.000156	0.000414	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—stomach cancer	0.000156	0.000414	CcSEcCtD
Zaleplon—Tension—Doxorubicin—stomach cancer	0.000156	0.000414	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—stomach cancer	0.000156	0.000413	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000155	0.000412	CcSEcCtD
Zaleplon—Malaise—Epirubicin—stomach cancer	0.000155	0.000411	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—stomach cancer	0.000154	0.000409	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—stomach cancer	0.000154	0.000409	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—stomach cancer	0.000154	0.000409	CcSEcCtD
Zaleplon—Syncope—Epirubicin—stomach cancer	0.000154	0.000409	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—stomach cancer	0.000154	0.000408	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—stomach cancer	0.000152	0.000403	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—stomach cancer	0.000151	0.000401	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—stomach cancer	0.000151	0.0004	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—stomach cancer	0.00015	0.000397	CcSEcCtD
Zaleplon—Asthenia—Docetaxel—stomach cancer	0.000149	0.000396	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—stomach cancer	0.000148	0.000393	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—stomach cancer	0.000147	0.000391	CcSEcCtD
Zaleplon—Pruritus—Docetaxel—stomach cancer	0.000147	0.00039	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—stomach cancer	0.000147	0.00039	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—stomach cancer	0.000147	0.00039	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—stomach cancer	0.000146	0.000388	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—stomach cancer	0.000146	0.000388	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—stomach cancer	0.000146	0.000388	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—stomach cancer	0.000146	0.000387	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—stomach cancer	0.000146	0.000387	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—stomach cancer	0.000145	0.000386	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000145	0.000385	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—stomach cancer	0.000145	0.000384	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—stomach cancer	0.000144	0.000383	CcSEcCtD
Zaleplon—Asthenia—Capecitabine—stomach cancer	0.000144	0.000383	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—stomach cancer	0.000143	0.00038	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—stomach cancer	0.000143	0.000379	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—stomach cancer	0.000143	0.000379	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—stomach cancer	0.000143	0.000379	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—stomach cancer	0.000143	0.000378	CcSEcCtD
Zaleplon—Pruritus—Capecitabine—stomach cancer	0.000142	0.000378	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—stomach cancer	0.000141	0.000375	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—stomach cancer	0.00014	0.000373	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—stomach cancer	0.00014	0.000372	CcSEcCtD
Zaleplon—Oedema—Epirubicin—stomach cancer	0.00014	0.000372	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—stomach cancer	0.00014	0.000371	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—stomach cancer	0.00014	0.00037	CcSEcCtD
Zaleplon—Shock—Epirubicin—stomach cancer	0.000138	0.000366	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—stomach cancer	0.000137	0.000365	CcSEcCtD
Zaleplon—Dizziness—Docetaxel—stomach cancer	0.000137	0.000365	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—stomach cancer	0.000137	0.000364	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—stomach cancer	0.000137	0.000363	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000136	0.000362	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—stomach cancer	0.000136	0.000361	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—stomach cancer	0.000136	0.000359	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—stomach cancer	0.000135	0.000359	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—stomach cancer	0.000135	0.000359	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—stomach cancer	0.000135	0.000359	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—stomach cancer	0.000135	0.000359	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—stomach cancer	0.000135	0.000358	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—stomach cancer	0.000134	0.000357	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000134	0.000356	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—stomach cancer	0.000134	0.000355	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—stomach cancer	0.000134	0.000354	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—stomach cancer	0.000134	0.000354	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—stomach cancer	0.000133	0.000353	CcSEcCtD
Zaleplon—Dizziness—Capecitabine—stomach cancer	0.000133	0.000353	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—stomach cancer	0.000132	0.000351	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—stomach cancer	0.000132	0.00035	CcSEcCtD
Zaleplon—Rash—Docetaxel—stomach cancer	0.000131	0.000348	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—stomach cancer	0.000131	0.000347	CcSEcCtD
Zaleplon—Dermatitis—Docetaxel—stomach cancer	0.000131	0.000347	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—stomach cancer	0.000131	0.000347	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—stomach cancer	0.00013	0.000345	CcSEcCtD
Zaleplon—Headache—Docetaxel—stomach cancer	0.00013	0.000345	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—stomach cancer	0.00013	0.000344	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—stomach cancer	0.00013	0.000344	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000129	0.000343	CcSEcCtD
Zaleplon—Pain—Methotrexate—stomach cancer	0.000128	0.00034	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000128	0.000339	CcSEcCtD
Zaleplon—Shock—Doxorubicin—stomach cancer	0.000128	0.000338	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—stomach cancer	0.000127	0.000337	CcSEcCtD
Zaleplon—Rash—Capecitabine—stomach cancer	0.000127	0.000337	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—stomach cancer	0.000127	0.000336	CcSEcCtD
Zaleplon—Dermatitis—Capecitabine—stomach cancer	0.000127	0.000336	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—stomach cancer	0.000127	0.000336	CcSEcCtD
Zaleplon—Headache—Capecitabine—stomach cancer	0.000126	0.000334	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—stomach cancer	0.000126	0.000334	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—stomach cancer	0.000126	0.000334	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—stomach cancer	0.000125	0.000333	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—stomach cancer	0.000125	0.000331	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—stomach cancer	0.000125	0.000331	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—stomach cancer	0.000124	0.000328	CcSEcCtD
Zaleplon—Nausea—Docetaxel—stomach cancer	0.000123	0.000327	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—stomach cancer	0.000123	0.000327	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—stomach cancer	0.000123	0.000327	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—stomach cancer	0.000122	0.000325	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—stomach cancer	0.000122	0.000323	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—stomach cancer	0.000121	0.000321	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000121	0.000321	CcSEcCtD
Zaleplon—Pain—Epirubicin—stomach cancer	0.00012	0.000318	CcSEcCtD
Zaleplon—Constipation—Epirubicin—stomach cancer	0.00012	0.000318	CcSEcCtD
Zaleplon—Nausea—Capecitabine—stomach cancer	0.00012	0.000317	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—stomach cancer	0.000119	0.000316	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—stomach cancer	0.000118	0.000314	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—stomach cancer	0.000118	0.000314	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000118	0.000313	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—stomach cancer	0.000117	0.000311	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—stomach cancer	0.000116	0.000309	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—stomach cancer	0.000116	0.000307	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—stomach cancer	0.000116	0.000306	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—stomach cancer	0.000115	0.000306	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—stomach cancer	0.000115	0.000304	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—stomach cancer	0.000114	0.000303	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—stomach cancer	0.000113	0.000299	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000112	0.000297	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—stomach cancer	0.000111	0.000295	CcSEcCtD
Zaleplon—Pain—Doxorubicin—stomach cancer	0.000111	0.000294	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—stomach cancer	0.000111	0.000294	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—stomach cancer	0.000111	0.000294	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—stomach cancer	0.000111	0.000294	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—stomach cancer	0.000107	0.000285	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—stomach cancer	0.000107	0.000283	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000106	0.000281	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—stomach cancer	0.000106	0.000281	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—stomach cancer	0.000103	0.000273	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—stomach cancer	0.000103	0.000272	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—stomach cancer	0.000103	0.000272	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—stomach cancer	0.000101	0.000267	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—stomach cancer	9.92e-05	0.000263	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—stomach cancer	9.9e-05	0.000263	CcSEcCtD
Zaleplon—Rash—Methotrexate—stomach cancer	9.44e-05	0.000251	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—stomach cancer	9.44e-05	0.00025	CcSEcCtD
Zaleplon—Headache—Methotrexate—stomach cancer	9.38e-05	0.000249	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—stomach cancer	9.31e-05	0.000247	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—stomach cancer	9.27e-05	0.000246	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—stomach cancer	9.18e-05	0.000243	CcSEcCtD
Zaleplon—Nausea—Methotrexate—stomach cancer	8.9e-05	0.000236	CcSEcCtD
Zaleplon—Rash—Epirubicin—stomach cancer	8.84e-05	0.000234	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—stomach cancer	8.83e-05	0.000234	CcSEcCtD
Zaleplon—Headache—Epirubicin—stomach cancer	8.78e-05	0.000233	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—stomach cancer	8.58e-05	0.000227	CcSEcCtD
Zaleplon—Nausea—Epirubicin—stomach cancer	8.33e-05	0.000221	CcSEcCtD
Zaleplon—Rash—Doxorubicin—stomach cancer	8.18e-05	0.000217	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—stomach cancer	8.17e-05	0.000217	CcSEcCtD
Zaleplon—Headache—Doxorubicin—stomach cancer	8.13e-05	0.000216	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—stomach cancer	7.7e-05	0.000204	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	1.15e-05	0.00136	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—STAT3—stomach cancer	1.15e-05	0.00136	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.14e-05	0.00136	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PGLS—stomach cancer	1.13e-05	0.00134	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BLVRB—stomach cancer	1.13e-05	0.00134	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL1B—stomach cancer	1.1e-05	0.0013	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPK3—stomach cancer	1.1e-05	0.0013	CbGpPWpGaD
Zaleplon—AOX1—Disease—RPS6—stomach cancer	1.08e-05	0.00128	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPAP2A—stomach cancer	1.08e-05	0.00128	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GMPR2—stomach cancer	1.08e-05	0.00127	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.07e-05	0.00127	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTT1—stomach cancer	1.07e-05	0.00126	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—JUN—stomach cancer	1.07e-05	0.00126	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.07e-05	0.00126	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD44—stomach cancer	1.06e-05	0.00125	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2A6—stomach cancer	1.05e-05	0.00125	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	1.05e-05	0.00124	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—MAPK1—stomach cancer	1.04e-05	0.00123	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKR1C3—stomach cancer	1.03e-05	0.00122	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—PRKCB—stomach cancer	1.02e-05	0.00121	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ENO1—stomach cancer	1e-05	0.00118	CbGpPWpGaD
Zaleplon—AOX1—Disease—HBEGF—stomach cancer	9.96e-06	0.00118	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—IDH3B—stomach cancer	9.84e-06	0.00117	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SUCLG1—stomach cancer	9.84e-06	0.00117	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CKB—stomach cancer	9.59e-06	0.00114	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NDUFA2—stomach cancer	9.59e-06	0.00114	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—FBP1—stomach cancer	9.59e-06	0.00114	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CA1—stomach cancer	9.59e-06	0.00114	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—HMOX1—stomach cancer	9.51e-06	0.00113	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTT1—stomach cancer	9.42e-06	0.00112	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	9.32e-06	0.0011	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	9.31e-06	0.0011	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	9.19e-06	0.00109	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NDUFV1—stomach cancer	9.15e-06	0.00108	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NDUFS1—stomach cancer	9.15e-06	0.00108	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	9.15e-06	0.00108	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLIN2—stomach cancer	9.02e-06	0.00107	CbGpPWpGaD
Zaleplon—AOX1—Disease—PPP2R1A—stomach cancer	9e-06	0.00107	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	8.93e-06	0.00106	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—HMOX1—stomach cancer	8.92e-06	0.00106	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CD44—stomach cancer	8.87e-06	0.00105	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—HMOX1—stomach cancer	8.86e-06	0.00105	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CA2—stomach cancer	8.77e-06	0.00104	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—HMOX1—stomach cancer	8.7e-06	0.00103	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	8.61e-06	0.00102	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—MAPK1—stomach cancer	8.6e-06	0.00102	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	8.56e-06	0.00101	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NT5E—stomach cancer	8.55e-06	0.00101	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PGAM1—stomach cancer	8.55e-06	0.00101	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	8.4e-06	0.000996	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—HRAS—stomach cancer	8.36e-06	0.000991	CbGpPWpGaD
Zaleplon—AOX1—Disease—SMAD4—stomach cancer	8.36e-06	0.000991	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLCE1—stomach cancer	8.15e-06	0.000966	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDH7A1—stomach cancer	8.15e-06	0.000966	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BLVRB—stomach cancer	8.15e-06	0.000966	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PGLS—stomach cancer	8.15e-06	0.000966	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—MAPK1—stomach cancer	8.06e-06	0.000956	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—MAPK1—stomach cancer	8.01e-06	0.000949	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—stomach cancer	7.99e-06	0.000946	CbGpPWpGaD
Zaleplon—AOX1—Disease—FYN—stomach cancer	7.94e-06	0.000941	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—MAPK1—stomach cancer	7.87e-06	0.000932	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—UMPS—stomach cancer	7.82e-06	0.000926	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPAP2A—stomach cancer	7.78e-06	0.000922	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERCC2—stomach cancer	7.63e-06	0.000904	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—HMOX1—stomach cancer	7.61e-06	0.000901	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPP2R1A—stomach cancer	7.54e-06	0.000894	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGFR2—stomach cancer	7.45e-06	0.000883	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTP1—stomach cancer	7.4e-06	0.000876	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	7.34e-06	0.00087	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMOX1—stomach cancer	7.29e-06	0.000864	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PDHA1—stomach cancer	7.27e-06	0.000861	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ECHS1—stomach cancer	7.27e-06	0.000861	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—APOA1—stomach cancer	7.21e-06	0.000854	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTHFR—stomach cancer	7.17e-06	0.00085	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CKB—stomach cancer	6.93e-06	0.000821	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CA1—stomach cancer	6.93e-06	0.000821	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—FBP1—stomach cancer	6.93e-06	0.000821	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NDUFA2—stomach cancer	6.93e-06	0.000821	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—HRAS—stomach cancer	6.91e-06	0.000818	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—MAPK1—stomach cancer	6.88e-06	0.000815	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—TYMS—stomach cancer	6.88e-06	0.000815	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—FADS1—stomach cancer	6.83e-06	0.00081	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TYMP—stomach cancer	6.83e-06	0.00081	CbGpPWpGaD
Zaleplon—AOX1—Disease—IRS2—stomach cancer	6.82e-06	0.000809	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTM1—stomach cancer	6.8e-06	0.000805	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—APOA1—stomach cancer	6.76e-06	0.000801	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—APOA1—stomach cancer	6.72e-06	0.000796	CbGpPWpGaD
Zaleplon—AOX1—Disease—CAV1—stomach cancer	6.62e-06	0.000784	CbGpPWpGaD
Zaleplon—AOX1—Disease—APOA1—stomach cancer	6.6e-06	0.000782	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—APOA1—stomach cancer	6.59e-06	0.000781	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—MAPK1—stomach cancer	6.59e-06	0.000781	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTP1—stomach cancer	6.53e-06	0.000773	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLIN2—stomach cancer	6.52e-06	0.000772	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—HRAS—stomach cancer	6.47e-06	0.000767	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—stomach cancer	6.45e-06	0.000764	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	6.44e-06	0.000763	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—HRAS—stomach cancer	6.43e-06	0.000762	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SREBF2—stomach cancer	6.4e-06	0.000758	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ERCC2—stomach cancer	6.39e-06	0.000757	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CA2—stomach cancer	6.34e-06	0.000751	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—RORA—stomach cancer	6.32e-06	0.000749	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—HRAS—stomach cancer	6.32e-06	0.000748	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6ST—stomach cancer	6.27e-06	0.000743	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NT5E—stomach cancer	6.18e-06	0.000732	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PGAM1—stomach cancer	6.18e-06	0.000732	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—MAPK1—stomach cancer	6.18e-06	0.000732	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—MAPK1—stomach cancer	6.14e-06	0.000727	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—MAPK1—stomach cancer	6.03e-06	0.000714	CbGpPWpGaD
Zaleplon—AOX1—Disease—APC—stomach cancer	6.03e-06	0.000714	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—MTHFR—stomach cancer	6.01e-06	0.000712	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTM1—stomach cancer	6e-06	0.000711	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDOB—stomach cancer	5.92e-06	0.000702	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	5.92e-06	0.000701	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLCE1—stomach cancer	5.89e-06	0.000698	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDH7A1—stomach cancer	5.89e-06	0.000698	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—APOA1—stomach cancer	5.76e-06	0.000683	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—stomach cancer	5.71e-06	0.000677	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—UMPS—stomach cancer	5.65e-06	0.00067	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ACAD8—stomach cancer	5.61e-06	0.000665	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6R—stomach cancer	5.6e-06	0.000663	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAV1—stomach cancer	5.54e-06	0.000657	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—APOA1—stomach cancer	5.53e-06	0.000655	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—HRAS—stomach cancer	5.52e-06	0.000654	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX5—stomach cancer	5.51e-06	0.000653	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—DPYD—stomach cancer	5.42e-06	0.000642	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—stomach cancer	5.36e-06	0.000635	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—stomach cancer	5.32e-06	0.00063	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—HRAS—stomach cancer	5.29e-06	0.000627	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—MAPK1—stomach cancer	5.27e-06	0.000624	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PDHA1—stomach cancer	5.25e-06	0.000623	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ECHS1—stomach cancer	5.25e-06	0.000623	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—stomach cancer	5.24e-06	0.000621	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—stomach cancer	5.22e-06	0.000619	CbGpPWpGaD
Zaleplon—AOX1—Disease—RHOA—stomach cancer	5.05e-06	0.000599	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—stomach cancer	5e-06	0.000593	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GMPR2—stomach cancer	5e-06	0.000593	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—HRAS—stomach cancer	4.96e-06	0.000588	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TYMP—stomach cancer	4.94e-06	0.000585	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—FADS1—stomach cancer	4.94e-06	0.000585	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—HRAS—stomach cancer	4.93e-06	0.000584	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARG—stomach cancer	4.87e-06	0.000577	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—HRAS—stomach cancer	4.84e-06	0.000573	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—stomach cancer	4.79e-06	0.000568	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2A6—stomach cancer	4.74e-06	0.000561	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB2—stomach cancer	4.68e-06	0.000554	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SREBF2—stomach cancer	4.63e-06	0.000548	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKR1C3—stomach cancer	4.61e-06	0.000546	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—stomach cancer	4.58e-06	0.000542	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.57e-06	0.000542	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—IDH3B—stomach cancer	4.57e-06	0.000542	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—RORA—stomach cancer	4.57e-06	0.000542	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—stomach cancer	4.57e-06	0.000541	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ENO1—stomach cancer	4.49e-06	0.000532	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—stomach cancer	4.38e-06	0.000519	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1B—stomach cancer	4.33e-06	0.000514	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDOB—stomach cancer	4.28e-06	0.000508	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NDUFS1—stomach cancer	4.25e-06	0.000504	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NDUFV1—stomach cancer	4.25e-06	0.000504	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—HRAS—stomach cancer	4.23e-06	0.000501	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—stomach cancer	4.19e-06	0.000496	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1A—stomach cancer	4e-06	0.000474	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CD44—stomach cancer	3.98e-06	0.000472	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX5—stomach cancer	3.98e-06	0.000472	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—DPYD—stomach cancer	3.92e-06	0.000464	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—stomach cancer	3.83e-06	0.000454	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BLVRB—stomach cancer	3.79e-06	0.000449	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PGLS—stomach cancer	3.79e-06	0.000449	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.62e-06	0.000428	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—stomach cancer	3.57e-06	0.000423	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—stomach cancer	3.46e-06	0.00041	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2A6—stomach cancer	3.42e-06	0.000406	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAPK3—stomach cancer	3.41e-06	0.000404	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPP2R1A—stomach cancer	3.39e-06	0.000401	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKR1C3—stomach cancer	3.33e-06	0.000395	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—stomach cancer	3.32e-06	0.000394	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—stomach cancer	3.32e-06	0.000393	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—stomach cancer	3.28e-06	0.000388	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ENO1—stomach cancer	3.25e-06	0.000385	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAPK1—stomach cancer	3.24e-06	0.000384	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—stomach cancer	3.24e-06	0.000384	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA1—stomach cancer	3.22e-06	0.000382	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.22e-06	0.000382	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CKB—stomach cancer	3.22e-06	0.000382	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FBP1—stomach cancer	3.22e-06	0.000382	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TYMS—stomach cancer	3.09e-06	0.000366	CbGpPWpGaD
Zaleplon—AOX1—Disease—KRAS—stomach cancer	3.06e-06	0.000363	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—stomach cancer	3.05e-06	0.000362	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLIN2—stomach cancer	3.03e-06	0.000359	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA2—stomach cancer	2.95e-06	0.000349	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CD44—stomach cancer	2.88e-06	0.000341	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PGAM1—stomach cancer	2.87e-06	0.00034	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NT5E—stomach cancer	2.87e-06	0.00034	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ERCC2—stomach cancer	2.87e-06	0.00034	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—stomach cancer	2.81e-06	0.000334	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.74e-06	0.000325	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLCE1—stomach cancer	2.74e-06	0.000325	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—stomach cancer	2.7e-06	0.00032	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UMPS—stomach cancer	2.63e-06	0.000311	CbGpPWpGaD
Zaleplon—AOX1—Disease—HRAS—stomach cancer	2.6e-06	0.000309	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—stomach cancer	2.49e-06	0.000295	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAV1—stomach cancer	2.49e-06	0.000295	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—APOA1—stomach cancer	2.48e-06	0.000294	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPP2R1A—stomach cancer	2.45e-06	0.00029	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PDHA1—stomach cancer	2.44e-06	0.000289	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ECHS1—stomach cancer	2.44e-06	0.000289	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—stomach cancer	2.4e-06	0.000285	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—stomach cancer	2.37e-06	0.000281	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—stomach cancer	2.36e-06	0.000279	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TYMP—stomach cancer	2.3e-06	0.000272	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FADS1—stomach cancer	2.3e-06	0.000272	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TYMS—stomach cancer	2.23e-06	0.000264	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—stomach cancer	2.21e-06	0.000261	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARG—stomach cancer	2.19e-06	0.000259	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SREBF2—stomach cancer	2.15e-06	0.000255	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—RORA—stomach cancer	2.12e-06	0.000252	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ERCC2—stomach cancer	2.07e-06	0.000246	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDOB—stomach cancer	1.99e-06	0.000236	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—stomach cancer	1.97e-06	0.000233	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—stomach cancer	1.95e-06	0.000231	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—stomach cancer	1.88e-06	0.000223	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX5—stomach cancer	1.85e-06	0.000219	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—DPYD—stomach cancer	1.82e-06	0.000216	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAV1—stomach cancer	1.8e-06	0.000213	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—APOA1—stomach cancer	1.79e-06	0.000213	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—stomach cancer	1.72e-06	0.000204	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—stomach cancer	1.61e-06	0.000191	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.59e-06	0.000189	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARG—stomach cancer	1.58e-06	0.000187	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.55e-06	0.000183	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENO1—stomach cancer	1.51e-06	0.000179	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—stomach cancer	1.42e-06	0.000168	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—stomach cancer	1.36e-06	0.000161	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CD44—stomach cancer	1.34e-06	0.000159	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—stomach cancer	1.24e-06	0.000147	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.14e-06	0.000135	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—stomach cancer	1.12e-06	0.000132	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—stomach cancer	1.1e-06	0.00013	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—stomach cancer	1.06e-06	0.000125	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TYMS—stomach cancer	1.04e-06	0.000123	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—stomach cancer	1.03e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ERCC2—stomach cancer	9.64e-07	0.000114	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—stomach cancer	9.06e-07	0.000107	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAV1—stomach cancer	8.36e-07	9.91e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APOA1—stomach cancer	8.34e-07	9.89e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—stomach cancer	7.65e-07	9.07e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARG—stomach cancer	7.35e-07	8.71e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—stomach cancer	6.61e-07	7.83e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—stomach cancer	6.32e-07	7.49e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—stomach cancer	5.78e-07	6.85e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.56e-07	4.22e-05	CbGpPWpGaD
